Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-κB Signaling

Demethyleneberberine (DMB) is an essential metabolite of Berberine (BBR) in vivo. Recent reports have revealed multiple novel therapeutic applications of BBR. However, the pharmacological activities of DMB remain to be elucidated. This study aimed to demonstrate the hepatoprotective and anti-fibroti...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Mol Sci
Huvudupphovsmän: Wang, Yongchen, Zhao, Zheng, Yan, Yan, Qiang, Xiaoyan, Zhou, Cuisong, Li, Ruiyan, Chen, Huan, Zhang, Yubin
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964412/
https://ncbi.nlm.nih.gov/pubmed/27376272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17071036
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk